Učitavanje...
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
To treat hypertension, combining two or more antihypertensive drugs from different classes is often necessary. β-Blockers and renin–angiotensin–aldosterone system inhibitors, when combined, have been deemed ‘less effective’ based on partially overlapping mechanisms of action and limited evidence. Re...
Spremljeno u:
| Izdano u: | J Hypertens |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Lippincott Williams & Wilkins
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548499/ https://ncbi.nlm.nih.gov/pubmed/28509722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HJH.0000000000001412 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|